US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

Baxter International Inc.

us-stock
To Invest in {{usstockname}}
us-stock
$18.89 0.0027(0.27%) BAX at 04 Dec 2025 04:26 PM Medical Instruments & Supplies
Lowest Today 18.86
Highest Today 19.16
Today’s Open 19
Prev. Close 18.84
52 Week High 37.25
52 Week Low 17.39
Day’s Range: Low 18.86 High 19.16
52-Week Range: Low 17.39 High 37.25
1 day return -
1 Week return +0.9
1 month return +5.32
3 month return -19.89
6 month return -36.94
1 year return -42.73
3 year return -63.16
5 year return -75.76
10 year return -

Institutional Holdings

BlackRock Inc 13.19

Vanguard Group Inc 12.11

Dodge & Cox 10.15

Pzena Investment Management, LLC 7.66

Dodge & Cox Stock I 6.87

T. Rowe Price Associates, Inc. 4.28

State Street Corp 4.27

Vanguard Total Stock Mkt Idx Inv 3.15

Bank of New York Mellon Corp 2.57

BlackRock Equity Dividend Instl 2.54

Geode Capital Management, LLC 2.51

Vanguard 500 Index Investor 2.47

Vanguard Mid Cap Index Institutional 2.23

Harris Associates L.P. 1.82

Amvescap Plc. 1.73

Pzena Large Cap Value 1.67

T. Rowe Price US Mid-Cap Value Equity 1.53

T. Rowe Price Mid-Cap Value 1.53

Ameriprise Financial Inc 1.49

Vanguard Windsor Investor Shares 1.36

Fidelity 500 Index 1.27

Oakmark Investor 1.26

State Farm Mutual Automobile Ins Co 1.21

SPDR® S&P 500® ETF 1.20

iShares Core S&P 500 ETF 1.20

Bank of America Corp 1.09

NORGES BANK 1.06

UBS Group AG 1.02

Morgan Stanley - Brokerage Accounts 1.01

Artisan Partners Limited Partnership 0.97

Franklin Resources Inc 0.94

LSV Asset Management 0.94

Northern Trust Corp 0.93

Vanguard Value Index Inv 0.89

Invesco S&P 500® Equal Weight ETF 0.88

T. Rowe Price U.S. Mid-Cap Val Eq Tr-D 0.83

Vanguard Selected Value Inv 0.72

The Health Care Select Sector SPDR® ETF 0.68

Bridge Builder Large Cap Value 0.67

Franklin Mutual Shares Z 0.64

Market Status

Strong Buy: 4

Buy: 2

Hold: 11

Sell: 0

Strong Sell: 1

Fundamentals

Market Cap 9684.81 M

PB Ratio 1.3545

PE Ratio 0.0

Enterprise Value 17794.18 M

Total Assets 25782.00 M

Volume 6094340

Company Financials

Annual Revenue FY24:4513000000 4513.0M, FY23:15280000000 15280.0M, FY22:15113000000 15113.0M, FY21:12784000000 12784.0M, FY20:11673000000 11673.0M

Annual Profit FY24:1701000000 1701.0M, FY23:5222000000 5222.0M, FY22:5397000000 5397.0M, FY21:5105000000 5105.0M, FY20:4587000000 4587.0M

Annual Net worth FY24:-312000000 -312.0M, FY23:2592000000 2592.0M, FY22:-2421000000 -2421.0M, FY21:1284000000 1284.0M, FY20:1102000000 1102.0M

Quarterly Revenue Q3/2025:2835000000 2835.0M, Q2/2025:2810000000 2810.0M, Q1/2025:2625000000 2625.0M, Q4/2024:2753000000 2753.0M, Q3/2024:2699000000 2699.0M

Quarterly Profit Q3/2025:950000000 950.0M, Q2/2025:1131000000 1131.0M, Q1/2025:861000000 861.0M, Q4/2024:959000000 959.0M, Q3/2024:1033000000 1033.0M

Quarterly Net worth Q3/2025:-46000000 -46.0M, Q2/2025:91000000 91.0M, Q1/2025:126000000 126.0M, Q4/2024:-512000000 -512.0M, Q3/2024:140000000 140.0M

Fund house & investment objective

Company Information Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It has an agreement with Celerity Pharmaceuticals, LLC to develop acute care generic injectable premix and oncolytic products. The company operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Organisation Medical Instruments & Supplies

Employees 38000

Industry Medical Instruments & Supplies

CEO Mr. Andrew P. Hider

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right